Breaking News, Collaborations & Alliances

Ritedose, Chargepoint Team Up for Bio Mfg. Project

CDMO selects ChargePoint’s AseptiSafe bio transfer solution

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The Ritedose Corporation, a contract development and manufacturing organization (CDMO) with a focus on inhalation and ophthalmic products, has partnered with ChargePoint Technology to ensure the sterility of its drug substance mixing process.   ChargePoint’s aseptic split butterfly valve (SBV) technology solves the issue of charging sterile drug substance into a mixing tank by providing a sealed means of transfer. It has been selected as a solution due to its cost and production benefits, such...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters